Trials / Withdrawn
WithdrawnNCT02953379
Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
Phase III, National, Multicenter, Randomized, Single-blind, Non-inferiority to Compare the Efficacy of Mometasone Nasal Gel Compared to Mometasone Nasal Spray in the Treatment of Persistent or Intermittent Allergic Rhinitis in Adults
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the non-inferiority of the clinical efficacy of the mometasone nasal gel in the treatment of allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EMS Mometasone gel | The patient should administer 2 spray in each nostril, once daily. |
| DRUG | Mometasone spray nasal | The patient should administer 2 spray in each nostril, once daily. |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2019-12-01
- Completion
- 2020-03-01
- First posted
- 2016-11-02
- Last updated
- 2020-11-04
Source: ClinicalTrials.gov record NCT02953379. Inclusion in this directory is not an endorsement.